[Efficacy of pulmonary resection for primary hepatocellular carcinoma patients with pulmonary metastasis].
OBJECTIVE
Pulmonary resection is considered as an active therapy for malignant tumor patients with pulmonary metastasis. This study was to evaluate the efficacy of pulmonary resection for primary hepatocellular carcinoma (HCC) patients with pulmonary metastasis.


METHODS
Clinicpathologic data and outcomes of 12 HCC patients underwent pulmonary resection due to pulmonary metastasis were analyzed.


RESULTS
Among the 12 patients, 9 had 1 or 2 pulmonary metastases, 1 of which had relapsed pulmonary metastasis after the first pulmonary resection; the other 3 patients who had 3 or more pulmonary metastases all recurred with pulmonary metastasis after the first pulmonary resection. The median survival time was 52 months after the first hepatectomy and 24 months after the first pulmonary resection. The overall 1-, 3-and 5-year survival rates were 100.0%,75.0% and 47.3% after the first hepatectomy, and 83.3%, 46.7% and 21.0% after the first pulmonary resection, respectively.


CONCLUSIONS
When intrahepatic recurrence is effectively controlled, HCC patients with 1 or 2 pulmonary metastases might benefit from pulmonary resection and achieve prolonged survival.
Liang
Wen-Chang
WC
Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
Guo
Rong-Ping
RP
Chen
Min-Shan
MS
Long
Hao
H
Shi
Ming
M
Wei
Wei
W
Zhang
Ya-Qi
YQ
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology*; D008175:Lung Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D015996:Survival Rate